Alembic Pharma inches up on receiving EIR for API Facility at Karakhadi

17 Mar 2020 Evaluate

Alembic Pharmaceuticals is currently trading at Rs. 534.00, up by 2.90 points or 0.55% from its previous closing of Rs. 531.10 on the BSE.

The scrip opened at Rs. 542.00 and has touched a high and low of Rs. 550.55 and Rs. 523.50 respectively. So far 6399 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 682.50 on 19-Feb-2020 and a 52 week low of Rs. 435.10 on 21-Jun-2019.

Last one week high and low of the scrip stood at Rs. 638.15 and Rs. 500.00 respectively. The current market cap of the company is Rs. 10023.39 crore.

The promoters holding in the company stood at 72.97%, while Institutions and Non-Institutions held 15.96% and 11.07% respectively.

Alembic Pharmaceuticals has received Establishment Inspection Report (EIR) from US Food and Drug Administration (USFDA) for the inspection carried out by them at its API Facility at Karakhadi during the period from January 13, 2020 to January 17, 2020.

Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907.

Alembic Pharma Share Price

885.65 -14.25 (-1.58%)
08-Dec-2025 12:26 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1799.90
Dr. Reddys Lab 1269.80
Cipla 1510.10
Zydus Lifesciences 929.00
Lupin 2080.10
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×